How to Navigate Proposed Changes to Substance Abuse Confidentiality Regulations
These proposed revisions are designed to improve information exchange across networks and to better integrate substance abuse information into patient care, while still maintaining confidentiality. Although these proposed revisions will require significant operational adjustments for substance abuse providers, health information exchanges, and clinical integration networks, there are a number of barriers to information sharing that have not been clarified in these rules.
Please join us for a Foley web conference on Tuesday, March 29, during which Digital Health Lawyer Leeann Habte and Hazelden Betty Ford Foundation General Counsel Jennifer Lohse will highlight how the revised regulations support information exchange and where providers will still need to tread very carefully to remain compliant.
Specific topics include:
- An overview of the revised regulations and where the biggest obstacles lie
- Where HIPAA and the Part 2 Rule intersect and where they require separate attention
- Unresolved issues regarding releasing patient-protected information to subcontractors
- How these rules would change consent requirements and what impediments remain
- How you can begin adjusting your policies and operations to prepare for changes
Comments on the proposed rules are due April 11, 2016.
Speakers
M. Leeann Habte, Senior Counsel, Foley & Lardner LLP
Jennifer Lohse, General Counsel, Hazelden Betty Ford Foundation
Moderator
Richard K. Rifenbark, Partner, Foley & Lardner LLP